Multiple studies confirm high effectiveness of key antimalarial drugs in Indonesia, Ethiopia, and for malaria prevention in HIV-positive pregnancies. Research shows DHA-PPQ, artemether-lumefantrine, and other treatments remain well-tolerated with no delayed parasite clearance. Findings support continued use of current treatment policies while emphasizing the need for ongoing monitoring.
Recent research identifies novel genetic causes for rare movement and neurodegenerative disorders, including CD99L2 variants in spastic ataxia, PPP2R5C as an Alzheimer's biomarker, and toxic polyglycine proteins in GGC repeat expansion diseases.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07352566 |
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis |
NOT_YET_RECRUITING | PHASE4 |
| NCT06083688 |
Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, Malawi |
COMPLETED | PHASE4 |
| NCT04704999 |
Southeast Asia Dose Optimization of Tafenoquine |
RECRUITING | PHASE4 |
